Grant Verstandig - Mar 24, 2022 Form 4 Insider Report for NexImmune, Inc. (NEXI)

Role
Director
Signature
/s/ Ilse Johnson, Attorney-in-fact
Stock symbol
NEXI
Transactions as of
Mar 24, 2022
Transactions value $
$750,274
Form type
4
Date filed
3/28/2022, 04:15 PM
Next filing
Jun 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEXI Common Stock Purchase $134K +40K +5.59% $3.35* 755K Mar 24, 2022 Direct F1
transaction NEXI Common Stock Purchase $545K +132K +17.44% $4.14* 887K Mar 25, 2022 Direct F2
transaction NEXI Common Stock Purchase $71.4K +19K +2.14% $3.76* 905K Mar 28, 2022 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.02 to $3.50, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
F2 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.56 to $4.30, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
F3 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.57 to $3.98, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.